HCA Healthcare price target raised to $315 from $310 at Oppenheimer

Oppenheimer raised the firm’s price target on HCA Healthcare to $315 from $310 and keeps an Outperform rating on the shares. HCA reported strong Q2 results and expects its margins to be stronger in 2H vs 1H, as labor trends continue to improve, the analyst tells investors in a research note. HCA should continue to outperform the market, the firm contends.